How should acute cholecystitis be diagnosed and managed, including appropriate imaging, laboratory evaluation, antibiotic regimen, and timing of laparoscopic cholecystectomy versus percutaneous cholecystostomy?

Acute Cholecystitis: Diagnosis and Management

Diagnostic Approach

Ultrasound is the first-line imaging modality for acute cholecystitis, demonstrating pericholecystic fluid, gallbladder wall thickening >3mm, gallstones, and sonographic Murphy's sign with 92-95% positive predictive value. 1

Laboratory Evaluation

• Obtain complete blood count, liver function tests (AST, ALT, alkaline phosphatase, bilirubin, GGT), and C-reactive protein at presentation 2
• Neutrophil count is the strongest laboratory predictor with 70% sensitivity and 66% specificity 3
• White blood cell elevation occurs in only 55% of cases; C-reactive protein elevation in 68% 2
• Combined clinical assessment, physical examination, and laboratory tests yield a positive likelihood ratio of 25.7 for diagnosis 3

Additional Imaging

• Order MRCP when common bile duct stones are suspected based on elevated bilirubin or alkaline phosphatase 1
• CT with IV contrast is indicated for complicated cases, unclear diagnosis, or when evaluating for perforation or abscess 1

---

Antibiotic Regimen

Uncomplicated Cholecystitis (Grade I-II)

For immunocompetent, hemodynamically stable patients with uncomplicated acute cholecystitis, initiate amoxicillin-clavulanate 2g/0.2g IV every 8 hours. 4, 1

Alternative regimens:

• Ceftriaxone 2g IV daily + metronidazole 500mg IV every 8 hours 4
• For β-lactam allergy: Eravacycline 1 mg/kg IV every 12 hours OR tigecycline 100mg loading dose then 50mg IV every 12 hours 4, 1

Complicated Cholecystitis (Grade III) or Sepsis

For unstable patients or those with organ dysfunction, administer piperacillin-tazobactam 4.5g IV every 6 hours within the first hour of recognition. 4, 3

Alternative: Cefepime 2g IV every 8 hours + metronidazole 500mg IV every 8 hours 4

Special Populations

• Healthcare-associated or nursing home patients: Use piperacillin-tazobactam or carbapenems due to higher MDRO prevalence; obtain intraoperative bile cultures 4, 3
• Immunosuppressed/transplant patients: Add enterococcal coverage to the chosen regimen 3

Duration of Antibiotics

Critical distinction based on source control:

• Uncomplicated cholecystitis with adequate source control (successful early cholecystectomy): Discontinue antibiotics within 24 hours postoperatively; no postoperative antibiotics are necessary 4, 1, 3
• Complicated cholecystitis (perforation, gangrene, abscess) with adequate source control: Continue for 3-5 days maximum 4, 3
• Patients unfit for surgery receiving medical management only: Continue antibiotics for maximum 7 days 1

---

Timing of Laparoscopic Cholecystectomy

Early laparoscopic cholecystectomy within 24-72 hours of diagnosis is superior to delayed surgery and should be performed in all operable patients with acute cholecystitis. 2, 5

Optimal Timing Window

• Ideal: Within 24-72 hours of hospital admission 2, 5
• Acceptable: Up to 7 days of hospital admission AND within 10 days of symptom onset 2, 1

Evidence for Early Surgery

The ACDC randomized trial (618 patients) demonstrated that immediate laparoscopic cholecystectomy within 24 hours resulted in:

• Significantly lower morbidity: 11.8% vs 34.4% in delayed group 5
• Shorter hospital stay: 5.4 days vs 10.0 days 5
• Lower costs: €2,919 vs €4,262 5
• No difference in conversion rates or mortality 5

High-Risk Patients

The CHOCOLATE randomized trial demonstrated that immediate laparoscopic cholecystectomy is superior to percutaneous transhepatic gallbladder drainage even in critically ill patients (APACHE 7-14). 2

• Major complications: 5% with early cholecystectomy vs 53% with PTGBD 2
• Mortality remained equivalent between groups 2
• Recurrent biliary events were the primary driver of complications in the PTGBD group 2

Special Populations

• Transplant patients: Perform cholecystectomy as soon as possible after diagnosis; laparoscopic approach is feasible and preferred 2
• Elderly patients: Age >65 years is NOT a contraindication but is a risk factor for conversion to open surgery 3
• Cirrhotic patients: Laparoscopic cholecystectomy remains feasible but carries higher conversion risk 3

---

Percutaneous Cholecystostomy

Percutaneous cholecystostomy should be reserved ONLY for patients who are absolutely unfit for surgery and have failed conservative management after 24-48 hours. 2

Indications (Strict)

• Prohibitive physiological derangement requiring damage control approach 3
• Patient refuses surgery 3
• Septic patient with gallbladder empyema who cannot tolerate anesthesia 2

Outcomes

• Success rate: 85.6% 2
• Procedure-related mortality: 0.36% 2
• 30-day mortality: 15.4% (reflects underlying patient comorbidity) 2
• In-hospital morbidity: 8.2-62% 2

Critical Limitations

• Cholecystostomy is NOT definitive therapy; it converts a septic patient into a non-septic patient but does not remove the diseased gallbladder 2, 3
• Interval cholecystectomy should be performed 4-6 weeks after stabilization when cholecystostomy is used as a bridge 3
• Cholecystostomy is contraindicated for perforated cholecystitis with peritonitis; immediate surgery is mandatory 3

---

When Early Surgery Cannot Be Performed

If early laparoscopic cholecystectomy cannot be performed within 7-10 days of symptom onset, delay surgery to at least 6 weeks after clinical presentation. 2, 1, 6

Risks of Delayed Approach

• 30% of patients develop recurrent gallstone-related complications during the interval period 2
• Readmission rate approaches 49% within 1 year 4
• 60% eventually undergo cholecystectomy 2

---

Common Pitfalls and Caveats

Antibiotic Stewardship

• Do NOT prescribe postoperative antibiotics reflexively for uncomplicated cholecystitis; two randomized trials confirm no benefit and this practice drives antimicrobial resistance 4
• Do NOT routinely cover enterococcus in community-acquired infections in immunocompetent patients; its pathogenic role is unclear 3

Surgical Timing Errors

• Avoid the 7-day to 6-week "danger zone" for elective surgery; inflammation peaks during this period, increasing conversion rates and complications 2, 6
• Do NOT delay surgery in stable patients to complete extensive workup; concurrent imaging addresses both gallbladder and other concerns 3

Misuse of Cholecystostomy

• Never use percutaneous drainage as definitive therapy for perforated cholecystitis with peritonitis; this significantly increases mortality 3
• Remove endoscopic metal stents within 4 weeks to prevent food impaction and recurrent cholecystitis 3

Risk Factor Recognition

Conversion to open surgery is predicted by:

• Age >65 years 3
• Male gender (conversion risk increases from 16% to 48.5%) 2
• Thickened gallbladder wall 3
• Diabetes mellitus 2, 3
• Previous upper abdominal surgery 2, 3

Conversion is NOT a surgical failure but an appropriate safety measure when anatomic identification is difficult. 3